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Abstract
Epidemiological studies have found an increased incidence of neurodevelopmental disorders in populations prenatally
exposed to selective serotonin reuptake inhibitors (SSRIs). Optical imaging provides a minimally invasive way to
determine if perinatal SSRI exposure has long-term effects on cortical function. Herein we probed the functional
neuroimaging effects of perinatal SSRI exposure in a fluoxetine (FLX)-exposed mouse model. While resting-state
homotopic contralateral functional connectivity was unperturbed, the evoked cortical response to forepaw stimulation
was altered in FLX mice. The stimulated cortex showed decreased activity for FLX versus controls, by both
hemodynamic responses [oxyhemoglobin (HbO2)] and neuronal calcium responses (Thy1-GCaMP6f fluorescence).
Significant alterations in both cortical HbO2 and calcium response amplitude were seen in the cortex ipsilateral to the
stimulated paw in FLX as compared to controls. The cortical regions of largest difference in activation between FLX and
controls also were consistent between HbO2 and calcium contrasts at the end of stimulation. Taken together, these
results suggest a global loss of response signal amplitude in FLX versus controls. These findings indicate that perinatal
SSRI exposure has long-term consequences on somatosensory cortical responses.
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Introduction
The serotonin (5HT) system and its proper development
are critical to typical neurologic function, and implicated in
a variety of neurodevelopmental processes and psychiat-
ric conditions (Vitalis and Parnavelas, 2003; O’Connell
et al., 2018). 5HT modulation is a common target for
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Significance Statement
Use of selective serotonin reuptake inhibitors (SSRIs) by pregnant women has increased in the past
decades, raising questions regarding the long-term effects of SSRI usage during pregnancy on offspring. In
order to isolate the effect of perinatal SSRI exposure from genetic variables or a maternal psychiatric
diagnosis, we used in vivo functional neuroimaging to examine adult cortical function both at rest and in
response to a somatosensory input in a mouse model of perinatal SSRI exposure. Our mousemodel displayed
no global disruption of brain function at rest when compared to controls, while its cortical response to a
somatosensory stimulus was reduced, as measured by both hemodynamics and excitatory calcium signaling.
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pharmaceuticals such as selective serotonin reuptake in-
hibitors (SSRIs), which are widely used for the treatment
of depression and anxiety (Linde et al., 2015), including in
an increasing proportion of pregnant women (Cooper
et al., 2007; Mitchell et al., 2011).
It is known that 5HT also plays key roles in brain de-
velopment (Vitalis and Parnavelas, 2003; Sodhi and
Sanders-Bush, 2004). At fetal stages, 5HT receptors are
already localized in the human thalamus (Wai et al., 2011),
and are required for proper development of sensory gat-
ing circuits (McCormick and Bal, 1994). The 5HT trans-
porter is also transiently expressed in thalamocortical
axons during development (Lebrand et al., 1996; Bonnin
et al., 2007), and altered 5HT activity, including that
achieved with early SSRI exposure, has been linked to
morphologic changes in the rat somatosensory cortex
and its thalamocortical afferents (Lee, 2009). However, an
important question remains whether the presence of
SSRIs during brain development alters somatosensory
connectivity specifically, or brain development generally,
in a manner that has long-term consequences.
Despite the increase in SSRI usage in pregnant women,
the full long-term effects of perinatal SSRI exposure are
unclear. Long-term developmental and emotional altera-
tions, such as increased anxiety (Lupattelli et al., 2018)
and depression (Malm et al., 2016; Liu et al., 2017) diag-
noses, have been observed in populations prenatally ex-
posed to SSRIs. Altered behavioral responses to pain
(Oberlander et al., 2002, 2005) and poor neonatal adap-
tion (Olivier et al., 2013) have also been noted in SSRI-
exposed infants. There is a lack of consensus regarding
whether some behavioral alterations can be directly linked
to prenatal SSRI exposure or if maternal psychiatric stress
plays a major role (Oberlander et al., 2007; Hanley et al.,
2015; Lupattelli et al., 2018). There also exists a lack of
data available regarding postpubertal effects. Because
human behavior is difficult to directly link to neural pertur-
bations, more immediate quantifiable phenotypes might be
obtainable through brain imaging.
Human brain imaging outcomes suggest both structural
and functional abnormalities in the perinatally-exposed
population. Compared to controls or infants with depressed
mothers, neonates with SSRI-treated mothers displayed
increased gray matter volume and white matter connec-
tivity in the amygdala and insula (Lugo-Candelas et al.,
2018). Functional neuroimaging studies observed con-
nectivity increases in infants’ auditory resting-state net-
work following prenatal SSRI exposure (Rotem-Kohavi
et al., 2019) and reduced interhemispheric connectivity in
EEG studies (Videman et al., 2017). However, functional
neuroimaging studies have not yet explored the effects of
perinatal SSRI exposure after the neonatal period or used
task-based studies to determine potential alterations in sen-
sory inputs. Human studies of perinatal SSRI exposure are
also complicated by the genetic and environmental hetero-
geneity that is intrinsic in any human population, as well as
the confounding influence of maternal diagnosis.
To ameliorate some of these problems, mouse models
provide an avenue to study the biological impact of one
isolated manipulation such as perinatal SSRI exposure in
a controlled genetic background and environment. In rodent
models, early developmental SSRI exposure has been as-
sociated with increased depression-like and anxiety-like be-
havior (Hansen et al., 1997; Ansorge, 2004; Gingrich et al.,
2017), as well as alterations in somatosensory-related be-
haviors (Lee, 2009; Maloney et al., 2018). Early postnatal
SSRI exposure in rats reduced dendritic complexity of
Layer V pyramidal neurons in motor cortex (Lee and Lee,
2012) and of thalamocortical afferents and Layer IV spiny
stellate neurons in somatosensory cortex (Lee, 2009).
Prenatal fluoxetine (FLX) exposure also reduced dendritic
complexity of layer 2/3 pyramidal neurons in P6–P9
mouse somatosensory cortex and remained even up to 16
months of age (Smit-Rigter et al., 2012). There however
remains a lack of functional neuroimaging literature ex-
amining SSRI exposure models that bridges the gap be-
tween morphologic and behavioral abnormalities.
We therefore imaged a mouse model of perinatal SSRI
exposure in vivo to characterize adult cortical function
both at rest and following sensory input. Because of the
close relationship between 5HT, SSRIs, and thalamocor-
tical projection development, we examined whether func-
tional neuroimaging of a perinatal SSRI exposure model
would uncover functional disruption globally as well as
specifically in somatosensory cortex, a region uniquely
vulnerable to SSRIs. We found that our mouse model of
early SSRI exposure displayed resting-state functional
connectivity similar to controls, yet exhibited a reduced
cortical response to somatosensory stimulation as




All procedures using mice were approved by the Wash-
ington University Institutional Animal Care and Use Com-
mittee and conducted in accordance with the approved
Animal Studies Protocol. Mice were housed in translucent
plastic cages measuring 28.5  17.5  12 cm with corn-
cob bedding and standard lab diet and water freely avail-
able. The colony room lighting was a 12/12 h light/dark
cycle, and the room temperature (20–22°C) and relative
humidity (50%) were controlled automatically.
Following the previously published description of a
perinatal SSRI exposure model (Maloney et al., 2018),
mouse dams were exposed to the SSRI FLX through
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drinking water (48 mg/d in 1% saccharin water) beginning
immediately before gestation and ending at pup postnatal
day 14. This exposure time period and dosage were
chosen to replicate the effects of usage of the maximum
recommended human dose of FLX (Marken and Munro,
2000) and to mirror the period of human pregnancy and
early life breastfeeding, as the final trimester of human
pregnancy is equivalent to the first week of life in a murine
mouse model, and the remaining week (postnatal days
8–14) during which the pups were exposed through their
mother’s milk mirrors a postbirth breastfeeding period.
The dose used was equivalent to the maximum recom-
mended human dose of 80 mg/d (Maloney et al., 2018).
Vehicle (VEH)-exposed dams received only 1% saccharin
drinking water. Dams were randomly assigned to treat-
ment groups.
Male and female adult mice (11–22 weeks of age),
age-matched at imaging and from multiple independent
litters of FLX and VEH dams, were used for imaging and
processed in five independent cohorts (cohort 1: n  7
FLX, 8 VEH; cohort 2: n  8 FLX, 10 VEH; cohort 3: n 
9 FLX, 8 VEH; cohort 4: n  9 FLX, 8 VEH; cohort 5: n 
17 FLX, 11 VEH). Both FLX and VEH groups included mice
of both sexes (see Table 1 for number of males and
females used in sex-specific analyses). Because this is a
novel study without a prior basis for effect size, a power
analysis using a standard estimated large effect size of
0.8 and with 80% power indicated a total sample size of
42 animals is required to reject the null hypothesis at the
0.05  level. Mice were imaged during their 6 A.M. to 6
P.M. light cycle, with FLX and VEH mice counterbalanced
across the imaging day. The health of the animals was
monitored, and no differences between groups was ob-
served. The experimenter was blinded to the treatment
condition during data acquisition, processing, and prelim-
inary analysis. Mice were excluded from analysis if move-
ment of the animal suggesting wakefulness was detected,
or from evoked response analysis if stimulation applica-
tion failed and no change from baseline was recorded.
The first two cohorts were wild type C57BL6/J (JAX:
000664), while the later three were Thy1-GCaMP6f on the
C57BL6/J background (JAX:024276). GCaMP6f expres-
sion allowed for population-based calcium recording from
cortical excitatory neurons, in addition to concurrently
acquired hemodynamics. All mice were fitted with a trans-
parent Plexiglas window to facilitate imaging. Briefly, mice
were sedated using isoflurane (3% induction, 1% main-
tenance, 0.5 l/min) with body temperature maintained at
37°C using a heating pad; the head was then shaved and
the mouse prepared for surgery in a stereotactic restraint.
An incision in the scalp was made along midline to expose
the skull, and the skin was retracted to expose an1-cm2
cortical field of view through the skull. A cranial window of
Plexiglas was affixed to the dorsal surface of the intact
skull using dental cement (C&B-Metabond, Parkell Inc.)
which allowed for chronic, repeatable imaging.
After a minimum of 48 h of postsurgery recovery, the
mice were anesthetized for imaging by intraperitoneal
injection of a ketamine/xylazine cocktail (86.9 mg/kg ket-
amine, 13.4 mg/kg xylazine, dosage 0.005 ml/kg) to avoid
burst suppression (Ferron et al., 2009), and maintained at
37°C by heating pad (mTCII, Cell Microcontrols). Insertion
of the mouse into the imaging apparatus was not initiated
until full transition to the anesthetized state was observed,
Table 1. Statistical summary for Figures 1-Figures 4
Figures Data structure Type of test n Statistical significance
1F Normal Student’s t test n  48 FLX, 42 VEH p  0.05 with Bonferroni correction
1J Normal Student’s t test n  34 FLX, 25 VEH p  0.05 with Bonferroni correction
2I Non-normal Wilcoxon rank-sum test n  30 FLX, 24 VEH Contralateral HbO: p  0.13;
ipsilateral HbO: p  0.0046;
Contralateral GCAMP6F: p  0.060;
ipsilateral GCAMP6F: p  0.0011
2I Non-normal Wilcoxon rank-sum test n  18 FLX, 11 VEH (males) Contralateral HbO: p  0.14;
ipsilateral HbO: p  0.010;
contralateral GCAMP6F: p  0.06;
ipsilateral GCAMP6F: p  0.038
2I Non-normal Wilcoxon rank-sum test n  12 FLX, 13 VEH (females) Contralateral HbO: p  0.23;
ipsilateral HbO: p  0.13;
contralateral GCAMP6F: p  0.36;
ipsilateral GCAMP6F: p  0.012
3D Non-normal Wilcoxon rank-sum test n  30 FLX, 24 VEH Contralateral HbO: p  0.050;
ipsilateral HbO: p  0.043;
contralateral GCAMP6F: p  0.028;
ipsilateral GCAMP6F: p  0.014
3-1A,C Non-normal Wilcoxon rank-sum test n  18 FLX, 11 VEH (males) Contralateral HbO: p  0.031;
ipsilateral HbO: p  0.15;
contralateral GCAMP6F: p  0.034;
ipsilateral GCAMP6F: p  0.34
3-1B,D Non-normal Wilcoxon rank-sum test n  12 FLX, 13 VEH (females) Contralateral HbO: p  0.12;
ipsilateral HbO: p  0.075;
contralateral GCAMP6F: p  0.32;
ipsilateral GCAMP6F: p  0.0042
4C Normal Student’s t test n  30 FLX, 24 VEH p  0.05 for regions displayed
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as measured by the absence of whisker movement or a
response to a toe-pinch stimulus. The mouse’s head and
imaging plane were secured using a platform mount
which attached to and stabilized the Plexiglas window
adhered to the mouse’s skull.
Optical imaging system
Sequential illumination was provided at four wave-
lengths by a ring of light-emitting diodes (LEDS: 478, 588,
610, and 625 nm; RLS-5B475-S, B5B-4343-TY, B5B-
435-30S, and OSCR5111A-WY, respectively; Roithner
Lasertehnik) 10 cm above the mouse’s head, following
the methods of White et al. (2011). Diffuse reflected light
was captured by a cooled, frame-transfer EMCCD cam-
era (iXon 897, Andor Technologies). Acquisition was syn-
chronized with the LEDs’ sequential illumination and
controlled via custom-written software (MATLAB, Math-
Works) at a frame rate of 30 Hz per LED. The field of view
was1 cm2 with an anterior-posterior view from olfactory
bulb to superior colliculus, consisting of 128  128 pixels
with pixel size of 80 m2. Cohorts 1 and 2 were imaged
on this system.
Optical/calcium fluorescence imaging system
Sequential illumination and fluorophore excitation was
provided by four LEDs situated 8 cm above the head
[454 (GCaMP excitation), 523, 595, and 640 nm], following
the methods of Wright et al. (2017; Fig. 1A). Diffuse re-
flected light and fluorescence emission was captured by a
cooled, frame-transfer EMCCD camera (iXon 897, Andor
Technologies). Acquisition was synchronized with the
LEDs’ sequential illumination and controlled via custom-
written software (MATLAB, MathWorks) at a frame rate of
16 Hz per LED. The field of view was 1 cm2 with an
anterior-posterior view from olfactory bulb to superior
colliculus consisting of an image plane sampled by 512 
512 pixels, which are binned 4  4 down to 128  128
pixels with on-chip binning. The resulting pixel size was
80 m2 on the mouse head. Cohorts 3–5 were imaged
on this system.
Functional connectivity
Functional connectivity data under anesthesia and
without stimulation (referred to here as resting state) was
collected in each mouse for up to 30 min, split into six
consecutive runs of 5 min (Fig. 1B). The first resting state
Figure 1. Resting-state homotopic contralateral functional connectivity in FLX mice does not significantly differ from VEH controls.
A, Optical fluorescence/OIS imaging system schematic: The cranial window lies directly below the camera as sequential illumination
is delivered from light sources nearby. See Extended Data Figure 1-1 for a representative mouse brain image in which pixels not
containing brain tissue are excluded from analysis and brain landmarks are identified. B, Representation of OIS and evoked response
imaging workflow. C–F, Map of mean HbO2 homotopic contralateral functional connectivity (Pearson’s r) in (C) FLX (n  48) and (D)
VEH (n  42) groups. E, Mean difference between FLX and VEH HbO2 maps (FLX-VEH). F, t statistic map of FLX-VEH groups
(uncorrected). G–J, Map of mean GCaMP6f (F) homotopic contralateral functional connectivity (Pearson’s r) in (G) FLX (n  34) and
(H) VEH (n  25) groups. I, Mean difference between FLX and VEH GCaMP6f maps (FLX-VEH). J, t statistic map of FLX-VEH groups
(uncorrected).
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run for each mouse was initiated approximately 3 min
following any stimulus application from previous data col-
lection blocks. Visual monitoring of the mouse was per-
formed throughout, and on the detection of whisking or
other movement indicating a return to wakefulness, the
imaging session was terminated and the mouse was re-
moved from the imaging system to complete its emer-
gence from the anesthetized state.
Forepaw stimulation
Electrical pulses were generated by an isolated pulse
stimulator (Modell 2100, A-M Systems) and administered
to the left forepaw by micro vascular clips (Roboz Surgical
Instrument Co.). Stimulation data were collected in three
consecutive runs of 5 min each. The block design was
modeled on existing fMRI and functional optical imaging
stimulation studies, in which mixed blocks of stimulation
and resting state are common. Although some fMRI stud-
ies have shown a subtle alteration of resting state due to
prior motor learning tasks (Albert et al., 2009; Zhang et al.,
2014), these effects have not been explored as exten-
sively with mice and optical intrinsic signal (OIS). In either
case, in this study we used the same design structure for
both groups of mice and thus the effect or lack of effect
would equally influence both groups. The 5-min run con-
sisted of five 1-min blocks; each with an initial 5-s rest
period, followed by 10 s of electrical stimulation (fre-
quency: 3 Hz, pulse duration: 300 s, current: 0.75 mA),
and 45 s of rest (Fig. 1A). The five 1-min blocks were later
block averaged for each stimulus trial.
Imaging data processing and analysis
Data were processed using MATLAB and an imaging
analysis pipeline following that previously described in the
literature (Bauer et al., 2014; Wright et al., 2017) with
modifications as described. For calcium imaging, approx-
imated absorption coefficients for GCaMP6 excitation
and emission were calculated and used to correct for
absorption of GCaMP6 fluorescence by hemodynamic
fluctuations, as described elsewhere (Ma et al., 2016). For
all cohorts, a binary brain mask was created by delineat-
ing brain borders in the field of view using the roipoly
function in MATLAB. Following a previously published
approach (White et al., 2011), the co-registration process-
ing began with defining an individual-specific binary brain
mask that was created for each mouse and used to
eliminate pixels not containing brain tissue (Extended
Data Fig. 1-1). Within the mouse images, we manually
labeled the locations of lambda, where superior colliculus
and cerebrum intersect at midline, and the anterior suture
between the olfactory bulb and cerebrum at midline.
These coordinates were then used to co-register all mice
to common Paxinos atlas space (Franklin and Paxinos,
2008) using a two-dimensional affine transformation.
Runs with light levels with 1% variance throughout the
time series were discarded. In addition to visual inspec-
tion, movement of the animal was tracked by calculating
pixel displacement for each run, and runs with detected
movement were subsequently discarded. The runs which
passed these quality-control steps were used to create
average functional connectivity maps or stimulus time
traces for each mouse. After quality control, for resting
state analysis an average of 70% of the data per mouse
was used, with a minimum requirement of 5 min of data
from each mouse. For stimulation an average of 80% of
the data per mouse was used, with a minimum of 5 min
(five stimulation presentations) of data from each mouse.
The processed resting-state functional connectivity and
evoked-response data produced were used to analyze
homotopic contralateral function connectivity (HCFC) and
change from baseline oxyhemoglobin (HbO2) or fluores-
cence (F) levels across time, respectively. Resting-state
analyses included hemodynamic data from cohorts 1–5
to maximize sample size, and calcium data from the
GCaMP-positive cohorts, cohorts 3–5. The forepaw stim-
ulation analyses used cohorts 1 and 2 to define regions of
interests (ROIs), which were then used to subsequently
analyze the hemodynamic and calcium response data
from cohorts 3–5. Figure 1C–F includes more mice than
Figure 1G–J because Figure 1C–F has hemodynamic
measures and includes the data of cohorts 1–5 to include
the maximum sample size. Figure 1G–J includes less mice
because it is a calcium measure and cohorts 1–2 were
GCaMP-negative and therefore had no fluorophore exci-
tation to record and average into the functional connec-
tivity maps.
Hemodynamic data were filtered to the 0.009- to
0.25-Hz band (stimulation data) or 0.009- to 0.08-Hz band
(resting-state data), whereas calcium signal was filtered to
the 0.1- to 6.0-Hz band (stimulation data) or 0.4- to 4.0-Hz
band (resting-state data). Global signal regression was
performed on all data to remove sources of variance,
except where indicated otherwise. An averaged map of
pixel-by-pixel comparisons of HCFC for each mouse was
produced by use of the brain mask and atlas-based mid-
line coordinates. Because the homotopic contralateral
connectivity methods compare pairs of pixels that are
reflections of each other between the left and right hemi-
sphere, the left and right hemisphere maps are mirror
images about midline. We therefore report via heat map
the connectivity coefficients in the left hemisphere and
display the dorsal cortical surface and its landmarks on
the right hemisphere, to provide anatomic context when
viewing the values displayed across midline.
Forepaw stimulation data were analyzed both across
time and at stimulus end (the mean of 11 frames sur-
rounding t 10 s). Each stimulus block was normalized to
mean baseline hemoglobin or calcium levels in the 5 s
before stimulus onset. To calculate change in hemoglobin
or calcium levels across time in cohorts 3–5, two ROIs
were defined using the independent t statistic map de-
rived from cohorts 1 and 2’s FLX-VEH differences at
stimulus end (Extended Data Fig. 2-1). A circle (r  15
pixels or1.2 mm) centered on the maximum HbO2 value
in stimulated right (contralateral) cortex was drawn to
produce one ROI, then reflected across midline to create
a homotopic ROI in left (ipsilateral) cortex. All half-
maximum t statistic pixels in the contralateral region and
half-minimum t statistic pixels in ipsilateral region were
identified (Extended Data Fig. 2-1D), and the time traces
of these pixels within each of the two regions (contralat-
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eral and ipsilateral) were averaged and plotted across
time. Pearson r values were Fisher z-transformed before
all mathematical operations.
Statistical analysis
All statistical comparisons were performed using
MATLAB v9.2 (MathWorks). Statistical analyses were per-
formed to determine if there was a significant difference
between FLX and VEH groups in stimulation and resting-
state trials. Statistical significance was determined by
two-tailed unpaired Student’s t tests in all instances ex-
cept where otherwise stated. For HCFC analyses, a t test
was performed for each brain pixel pair and represented
by a heat map value in that pixel within the cortical image.
With the data smoothed by a Gaussian blur with full width
at half maximum of 0.096 mm, and a field of view of 22.9
mm2, an estimated 792 independent measures exist. The
minimum uncorrected p value is 0.0015 (HbO2) or 6.85E-4
(Ca2), but with a Bonferroni correction, performed for
792 tests, the corrected p value threshold is 6E-5, and
therefore none of the comparisons survive correction as
they are at least an order of magnitude too high. A one-
tailed Wilcoxon rank-sum test based on the direction of
effect from cohorts 1 and 2’s FLX-VEH differences was
used to assess differences in mean signal in the Con-
tralateral and Ipsilateral ROIs at end of stimulation. A
one-tailed Wilcoxon rank-sum test was also used to as-
sess differences in area under the curve (AUC) from the
onset to end of stimulation between FLX and VEH groups.
All pixel-by-pixel comparisons were Bonferroni corrected
unless otherwise stated. A critical  of 0.05 was used for
all tests to determine significance.
Results
Resting-state hemodynamics remain unaltered
following maternal FLX exposure
To determine whether transient developmental FLX ex-
posure can result in long-term alterations in functional
connectivity observable in adulthood, we examined FLX-
exposed mice for changes in resting-state functional
connectivity using an OIS imaging system. We assessed
cortical activity in 45 mice per condition, across five
cohorts, using both direct measures of neuronal activity
(Ca2 imaging, cohorts 3–5) as well as hemodynamics
(cohorts 1–5), representing the kind of indirect assess-
ment that would be available in humans.
In the absence of a task or applied stimulus, correlation
between individual cortical regions is used to operation-
ally define resting-state functional connectivity indepen-
dent of structural connectivity (Biswal et al., 1995).
Specifically, functional connectivity between correspond-
ing regions across hemispheres is high because of the
regions’ similar functions, as exemplified by the correla-
tion between left and right motor areas. This homotopic
contralateral functional connectivity (HCFC) can be as-
sessed to identify disruption in disease models (Bauer
et al., 2014). Comparison of HCFC between FLX and VEH
groups (Fig. 1C–F) identified no significant alterations in
the cortex: The HbO2 HCFC patterns in FLX (Fig. 1C) and
VEH (Fig. 1D) groups did not significantly diverge from
each other in the HbO2 signal (t test, p  0.05 with
Bonferroni correction; Fig. 1E,F). The GCaMP6f calcium
data collected simultaneously with the hemodynamic data
in cohorts 3–5 also showed a lack of significant difference
(Fig. 1I,J) between FLX (Fig. 1G) and VEH (Fig. 1H) HCFC
maps (t test, p  0.05 with Bonferroni correction). This
finding confirmed that the similarity in FLX and VEH
resting-state HCFC patterns seen in HbO2 were also re-
flected in calcium. Developmental FLX exposure therefore
did not significantly alter resting-state HCFC as assessed
by either hemodynamics or a more direct calcium-based
measure of neural activity.
Developmental FLX exposure alters stimulus-
induced cortical hemodynamics and calcium activity
Sensory aberrations such as altered behavioral responses
to pain have previously been reported in neonates with
prenatal SSRI exposure and the critical, transient 5HT role in
the development of thalamocortical projections suggests
that perception or management of sensory stimuli may be
altered in individuals with perinatal FLX exposure (McCor-
mick and Bal, 1994; Lebrand et al., 1996; Allen et al.,
2017). To probe whether developmental FLX exposure
alters sensory responsiveness to environmental stimuli,
we therefore examined the evoked cortical response to a
somatosensory stimulus. Left forepaw stimulation was
applied to FLX and VEH mice in a block design, and
changes in HbO2 and calcium signal were measured
cortex-wide. The stimulation data of the GCaMP6f-
negative cohorts 1 and 2 (Extended Data Fig. 2-1) were
used to define ROIs that were subsequently used to
evaluate cohorts 3–5’s HbO2 and calcium responses (Fig.
2). As expected, the observed region of greatest activa-
tion in all groups was the forepaw region of the somato-
sensory cortex, as defined by the cortical regions in the
Paxinos histologic atlas (Franklin and Paxinos, 2008) and
adapted to be a dorsal-view cortical map in White et al.
(2011; Extended Data Fig. 2-2). HbO2 response at the end
of the 10-s stimulation block (t  10 s) identified ROIs in
both the contralateral and ipsilateral cortices, with the FLX
group (Fig. 2A) displaying decreased HbO2 amplitude
compared to the VEH controls (Fig. 2B) in the contralateral
region focused over the stimulated somatosensory cortex
(Fig. 2C,D). A comparative increase of HbO2 in ipsilateral
cortex in FLX as compared to VEH is also evident at end
of stimulation (Fig. 2D). As HbO2 is only an indirect mea-
sure of neural activity, this result could reflect either
changes in neural activity or in hemodynamics. Therefore,
we also examined calcium transients in our GCaMP6f
cohorts. This decrease in contralateral activation and
comparative increase in ipsilateral cortical activity during
and immediately following stimulation was observed in
the three GCaMP6f cohorts’ calcium dynamics as well
(Fig. 2E–H), confirming that underlying neural activity is
altered on somatosensory stimulation. Contralateral and
ipsilateral ROIs for analysis of cohorts 3–5 were defined
by GCaMP-negative cohort 1 and 2’s mean HbO2 maps,
which displayed an increase in ipsilateral signal and de-
crease in contralateral signal within these ROIs in FLX
compared to VEH (Extended Data Fig. 2-1). Similarly,
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Figure 2. Mean HbO2 and calcium response to left forepaw stimulation at t  10 s is decreased in FLX contralateral somatosensory
cortex and increased in ipsilateral cortex. A, B, Map of mean HbO2 (mM) in (A) FLX (n  30) and (B) VEH (n  24) groups. See
Extended Data Figure 2-2 for the mean HbO2 activation map overlaid with cortical region boundaries as defined by the Paxinos atlas.
C, Mean difference between FLX and VEH HbO2 maps (FLX-VEH). D, t statistic map of FLX-VEH HbO2 (uncorrected). E, F, Map of
mean GCaMP6f calcium signal (F) in (E) FLX (n 30) and (F) VEH (n 24) groups. G, Mean difference between FLX and VEH calcium
maps (FLX-VEH). H, t statistic map of FLX-VEH calcium groups (uncorrected). I, Boxplots and scatterplots of HbO2 (first row) and
GCaMP6f (second row) changes from baseline at t  10 s in contralateral (left) and ipsilateral (right) ROIs defined by the independent
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cohorts 3–5 displayed an increase in ipsilateral ROI signal
in both contrasts (Wilcoxon rank-sum test; HbO2 p 
0.0046, Ca2 p  0.0011), although the contralateral
ROI’s decrease in both HbO2 and calcium signal was not
significant (Wilcoxon rank-sum test; HbO2 p  0.13, Ca
2
p  0.060; Fig. 2I). When animals of each sex were
analyzed separately, the same significant increase in ip-
silateral ROI signal was observed in males’ HbO2 and
calcium response as well as females’ calcium signal (Wil-
coxon rank-sum test; males HbO2 p  0.010, Ca
2 p 
0.038, females HbO2 p  0.13, Ca
2 p  0.012; Table 1).
The reduction in HbO2 and calcium absolute signal am-
plitude in the ipsilateral response typically observed in
VEH controls therefore demonstrates that developmental
FLX exposure alters the strength of the cortical activity
evoked by somatosensory stimulation.
Developmental FLX exposure decreases cortical
activation contralateral to the stimulated paw and
reduces ipsilateral inhibition
The analysis above defined regions that at a single time
point, following stimulation, show differences between
FLX and VEH groups in multiple cortical regions. We
therefore reanalyzed the data from cohorts 3–5 to deter-
mine whether this effect is consistent across time. Mean
HbO2 and calcium activity of the two ROIs (contralateral
and ipsilateral to the stimulated paw) were traced across
the 60-s stimulation block. These regions were defined
relative to the stimulated paw and included contralateral
and ipsilateral ROIs (Extended Data Fig. 2-1). FLX mice
displayed a mean decrease in HbO2 signal amplitude
compared to the VEH group in the contralateral ROI dur-
ing the 10-s stimulation block (Fig. 3A). As the end of
stimulation (t  10 s) approached, absolute HbO2 signal
amplitude in the ipsilateral ROI also decreased in the FLX
group as compared to VEH (Fig. 3A). HbO2 AUC from the
onset to end of stimulation for the contralateral and ipsi-
lateral ROIs were both significantly different in the FLX
mice compared to VEH (Wilcoxon rank-sum test; con-
tralateral AUC p  0.050, ipsilateral AUC p  0.043; Fig.
3D). This AUC finding was replicated in the calcium signal,
which displayed significant differences in both ROIs
(Wilcoxon rank-sum test; contralateral AUC p  0.028,
ipsilateral AUC p  0.014; Fig. 3B–D). Although not de-
liberately powered for analysis by sex, when analyzed
separately, males displayed a significant decrease in both
the HbO2 and calcium contralateral response magnitude
(AUC of the contralateral ROI response), while females did
not display a significant decrease in HbO2 contralateral
response magnitude (contralateral ROI AUC in the HbO2
signal, Wilcoxon rank-sum test; males HbO2 contralateral
AUC p  0.031, Ca2 p  0.034, females contralateral
HbO2 AUC p  0.12, Ca
2 p  0.32; Extended Data Fig.
3-1; Table 1). In the ipsilateral ROI response, FLX and VEH
groups analyzed as distinct male or female populations
were not significantly different but females displayed a
trend toward increased ipsilateral ROI AUC in the HbO2
signal and demonstrated a significant increase in ipsilat-
eral AUC response in the calcium signal (Wilcoxon rank-
sum test; males HbO2 ipsilateral AUC p  0.15, Ca
2 p 
0.34, females HbO2 ipsilateral AUC p  0.075, Ca
2 p 
0.0042; Extended Data Fig. 3-1; Table 1). These results
confirmed that the differences in signal intensity observed
at the end of the 10-s stimulation block were consistently
observed across time during the application of the so-
matosensory stimulus. Of particular note, the calcium and
hemodynamic signals display the same gross difference
across time and suggest that HbO2 is indeed reflecting an
underlying neural deficit.
Abnormalities in HbO2 and calcium evoked response
co-localize in the cortex
While the calcium and hemodynamic signals both dif-
fered significantly in the same direction within the two
ROIs described, it was unclear whether abnormalities in
HbO2 and GCaMP6f would occur together in other corti-
cal areas. We therefore evaluated if the calcium and he-
modynamic signals spatially co-localized in areas outside
of the two ROIs by overlaying binary cortical maps for
each contrast that represented each pixel where there
was a significant FLX-VEH difference (p  0.05, uncor-
rected; Fig. 4). HbO2 and calcium displayed an overlap-
ping area of strong FLX-VEH difference in contralateral
cortex and a co-localization region in ipsilateral cortex of
1.5 mm2. This suggests that the two contrasts overall
show similar activation patterns in response to somato-
sensory stimulation.
Discussion
Overall, the changes observed in evoked response but
not functional connectivity in this mouse model of perina-
tal or developmental SSRI exposure suggest that sensory
information processing is more strongly affected by this
environmental influence than resting state functional con-
nectivity is. The lack of significant difference in homotopic
contralateral functional connectivity that we found sug-
gests that the correlation structure in baseline hemody-
namic and neuronal dynamics are largely undisturbed in
the FLX mouse cortex. This lack of significant result may
also reflect, however, the severity or variability in pheno-
type that results from perinatal SSRI exposure. With a
relatively large sample size of 40 mice per group, it
would be reasonable to expect that even a relatively small
effect would be identified. However, perinatal SSRI expo-
sure in humans, if it does contribute to risk beyond ma-
ternal diagnosis, has a modest effect size and thus does
not lead to a diagnosis of psychiatric illness or other
neurodevelopmental conditions in a high percentage of
cases (Malm et al., 2016; Gingrich et al., 2017). If mice
also show this variable penetrance, then future studies
might leverage a behavioral variable or other metric to
stratify data for further analysis.
continued
dataset of cohorts 1 and 2 (see Extended Data Fig. 2-1 for ROI boundaries and the maps from cohorts 1 and 2 by which the ROIs
are defined). Sex of individuals within FLX and VEH groups indicated by blue (males) and black (females).
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Figure 3. HbO2 and Ca
2 response amplitude is decreased in ROI contralateral to stimulated forepaw and altered in ipsilateral ROI.
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In contrast to the resting state analysis, the abnormal-
ities observed in cortical response to forepaw stimulation
showed a reliable effect, detectable across three cohorts.
This suggests that perinatal SSRI exposure alters sensory
processing or gating in a way that has lasting repercussions
observable even in adulthood. The reduced response in
cortex contralateral to the stimulated paw as well as
reduced negative ipsilateral signal during stimulation trials
indicates that somatosensory inputs are abnormally re-
ceived or processed in the cortex. The abnormal cortical
response in ipsilateral cortex suggests reduced inhibition,
which may be caused by thalamocortical dysfunction
linked to morphologic abnormalities previously reported
in the literature from SSRI exposure (Lee and Lee, 2012).
Suppression of activity in ipsilateral somatosensory cor-
tex during stimulus presentation plays a role in the suc-
cessful execution of sensory gating (Staines et al., 2002)
and, by extension, the ability to process and react to
sensory stimuli in an organism’s environment as needed.
Abnormal ipsilateral cortical inhibition suggests that de-
velopmental SSRI exposure causes long-term sensory
gating and processing abnormalities. The left forepaw
was exclusively stimulated in these assays, but similar
effects would be expected if right forepaw was stimulated
instead, due to the equal number of left-handed and
right-handed individuals in the C57Bl/6J population (Col-
lins, 1968).
Finally, the abnormalities in cortical response following
perinatal SSRI exposure we detected suggest that HbO2
and GCaMP calcium dynamics during somatosensory
stimulation are coupled temporally and spatially across
the cortex. During stimulation, both contrasts displayed a
loss of signal amplitude in contralateral ROI and abnor-
malities in ipsilateral cortex. The cortical regions with the
largest FLX-VEH differences in HbO2 and calcium also
displayed significant overlap at the end of stimulation.
This suggests that altered neurovascular coupling is not
the immediate underlying cause for the HbO2 deficits we
observe following perinatal SSRI exposure. Future studies
might leverage this finding as added confirmation that
hemodynamic methods or blood oxygen level-dependent
methods in humans are a valid way to examine neural
activity in 5HT dysfunction or following early SSRI expo-
sure in humans or mammalian experimental systems.
This abnormal cortical response to somatosensory
stimulation following perinatal FLX exposure that we have
described here appears to reflect and further characterize
the same underlying phenomenon as other deficits re-
ported in the literature. Early SSRI exposure in rodents
has previously been linked to long-term morphologic
changes to both the somatosensory cortex and thalamo-
cortical afferents to the region (Lee, 2009; Smit-Rigter
et al., 2012). Alterations in somatosensory-related behav-
iors have also been observed (Lee, 2009; Maloney et al.,
2018), but behavior phenotypes are complex and difficult
to directly link to neural alterations. This functional neu-
roimaging phenotype, which suggests sensory gating or
processing abnormalities on a circuit level, helps bridge
the gap between morphologic and behavioral effects of
perinatal SSRI exposure.
We used both sexes of animals so that our results
would be more generalizable, and although our study was
not deliberately powered for analysis by sex, post hoc the
trends seen in the evoked response to forepaw stimula-
continued
A, Block-averaged time trace of mean HbO2 response to forepaw stimulation in each ROI (FLX n  30, VEH n  24; black 
contralateral, blue ipsilateral). Left forepaw stimulation at 3 Hz applied t 0 s to t 10 s. B, Block-averaged time trace of GCaMP6
Ca2 response to forepaw stimulation in each ROI (FLX n  30, VEH n  24; black  contralateral, blue  ipsilateral). Left forepaw
stimulation at 3 Hz applied t  0 s to t  10 s. C, Detail of block-averaged time trace of mean GCaMP6 Ca2 response to forepaw
stimulation during time of stimulation (t  0–10 s; FLX n  30, VEH n  24). Vertical black lines represent timing of 3-Hz stimulus
presentation. D, Boxplots and scatterplots of HbO2 (first row) and GCaMP6f (second row) AUC for contralateral (left) and ipsilateral
(right) cortical ROIs during stimulation (t  0–10 s). Sex of individuals within FLX and VEH groups indicated by blue (males) and black
(females). See Extended Data Fig. 3-1 for block-averaged time traces separated by sex.
Figure 4. Increases in FLX mice’s HbO2 and calcium response co-localize in cortex ipsilateral to forepaw stimulation. A, HbO2
t statistic map of FLX-VEH (uncorrected; FLX n  30, VEH n  24). B, GCaMP6f t statistic map of FLX-VEH (uncorrected; FLX
n  30, VEH n  24). C, Overlay figure of HbO2 and GCaMP6f uncorrected p  0.05 maps (blue  HbO2, yellow  GCaMP6f,
green  both).
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tion suggest that female and male brains respond similarly
to perinatal SSRI exposure. It is true that in both the
hemodynamic and calcium measures, differences in males’
contralateral response and females’ ipsilateral response
appeared more prominent, suggesting that further studies
focused on sex differences could be a promising research
direction. Limitations of this study also provide avenues
for further research into the effects of perinatal SSRI
exposure. Although necessary for our forepaw stimulation
paradigm, imaging mice under the effects of anesthesia
may introduce confounds to neuroimaging results (Wright
et al., 2017), and therefore a study of resting-state dy-
namics or evoked response in wakefulness using visual or
whisker stimulation (Berwick et al., 2002; Martin et al.,
2013; Carandini et al., 2015; Xiao et al., 2017) could
identify functional neurophenotypes that we were under-
powered to observe. In addition, we documented the
effects of perinatal SSRI exposure in adulthood, but per-
forming similar neuroimaging assays at earlier timepoints
during development (Kozberg et al., 2016) would help
elucidate the developmental trajectory of these functional
abnormalities and potentially serve as a biomarker to
determine what portion of the exposed population may
develop long-term deficits. Comparison of individuals’
somatosensory stimulation response in the cortex with
their performance on tactile behavioral assays such as the
von Frey test of somatosensation should also be consid-
ered, as it has previously been shown to be sensitive to
developmental SSRI exposure perturbations (Maloney
et al., 2018), and has the potential to provide insights into
individual variability in populations developmentally ex-
posed to SSRIs. In future studies it will be important
to consider using functional MRI in mice, to evaluate
whether these OIS hemodynamic findings are replicated
using fMRI’s BOLD signal and potentially explore subcortical
elements of the circuit in which the abnormal evoked so-
matosensory response was observed. Future functional
neuroimaging studies in awake mice or at earlier stages in
development would provide important information on the
long-term effects of perinatal SSRI exposure or other
genetic and environmental perturbations affecting neuro-
development.
Taken together, our findings provide evidence that peri-
natal SSRI exposure causes long-term functional deficits
observable in the brain in adulthood. While we did not
observe changes in resting-state dynamics between ho-
motopic contralateral regions, cortical response to so-
matosensory stimulation was altered in FLX mice. The
observed altered responses in both cortical hemispheres
after perinatal exposure to an SSRI suggest that the
evoked cortical response is both diminished in magnitude
and slightly shifted spatially compared to the response in
the healthy brain, and bridges the morphologic and be-
havioral phenotypic abnormalities previously seen in
models of early SSRI exposure.
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